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ABSTRACT
Background - Non-Compliance to tuberculosis treatment is an important barrier for
tuberculosis control programs because incomplete treatment may result in prolonged
infectiousness, drug resistance, relapse, and death.
Objective: The objective of this study was to assess treatment compliance rate and
associated factors among registered tuberculosis patients at public and private directly
observed therapy short course centers in Dessie and Kombolcha, North East Ethiopia.
Methods: Facility based comparative cross sectional study was carried out among 304
tuberculosis patients attending anti tuberculosis treatment in Dessie and Kombolcha,
public and private directly observed therapy short course centers. The study population
was all individuals aged ≥18 years. Study subjects were selected using simple random
sampling methods using patient’s registration number as a frame. The Data was
collected using standardized, well structured and pre-tested questionnaires which
include socio-demographic and relevant compliance related variables by trained data
collectors. Both bivariate and multivariate logistic regression techniques were used to
analyze the data using statistical package for social science version 16.
Results
The rate of treatment non compliance was higher among patients managed at the
private tuberculosis clinic (32.2%) as compared to patients managed by the public
tuberculosis clinic (27.6%). Forgetfulness, use of addictive substance and unavailability
of drug remained significant predictor of noncompliance both in public and private
tuberculosis clinics. Herbal medication use was remained significantly associated with
the level of treatment compliance only among patients attending public tuberculosis
clinics, AOR (95% CI) = 5.646(2.12, 15.05). Unlike patients at public tuberculosis clinics
monthly income, knowledge about tuberculosis, closure of tuberculosis clinic and health
education shows significant association with noncompliance at private tuberculosis
clinic.
Conclusion/recommendation
Forgetfulness, use of addictive substance and unavailability of drug were found to be
the three most important factors, leading to treatment noncompliance both in public and
private TB clinics. Administrative, organizational and behavioral changes involving
DOTS clinics, the community, the patients and the families are necessary to improve
treatment compliance. Ultimately health care professionals should provide continuous
education for patients regarding the danger of treatment noncompliance. This will
promote the more efficacious performance of Public Private Mix DOTS in TB control
program.
Key word: Noncompliance, Public Private Mix-DOTS, Treatment Interruption
11. INTROCUCTION
1.1. Statement of the problem
In 2010, there were an estimated 8.8 million incident cases of TB globally, equivalent to
128 cases per 100 000 population. Ethiopia ranks seventh among the world's 22
countries with high tuberculosis burden, these countries accounts for 81% of all
estimated cases worldwide. The incidence of TB of all forms and smear positive TB in
Ethiopia stands at 261 and 152 per 100,000 population, respectively with a mortality of
tuberculosis of all forms excluding HIV is estimated to be 35 per 100,000 populations
(1).
According to the World Health Organization (WHO), directly observed therapy short
course (DOTS) ensures successful treatment of patients with tuberculosis. Ethiopia has
used DOTS since 1992, but it was limited to public health facilities until 2006. However,
the FMOH had a strong interest in expanding DOTS services in line with WHO global
recommendations to involve the private sector in the delivery of TB service (2). As of
December-2010 there is 213 public private mix (PPM) sites providing DOTS in Ethiopia,
of this 35 are in Amhara region (3). Despite a rapid expansion of TB health care
facilities tuberculosis remains the leading cause of morbidity, the third cause of hospital
admission and the second cause of death in Ethiopia (4).
Non-compliance with tuberculosis treatment has many adverse consequences, not only
for patients and their families, but also for society, in the form of increased drug
resistance. The data from drug sensitivity test(DST) survey conducted in Ethiopia
between 2003 and 2006 shows that the level of MDR-TB are 1.6% and 11.8% in new
cases and re-treatment cases of TB patients, respectively(5). MDR-TB reflects the poor
primary management of the disease. It is mainly caused by the failure to ensure
compliance, rather than the failure of the drugs to cure. The highest priority in fighting
MDR-TB therefore must be its prevention (5). A case control study in Uganda
conducted to determine the predictors of treatment failure among patients with sputum
smear positive pulmonary TB shows poor adherence to anti TB treatment (OR 14.59,
95%CI 3.04-70.15) is a significant predictors of treatment failure (6).
2Another similar study done in Egypt shows non compliance is significant risk factor for
treatment failure (7).  A study aimed to identify factors associated with tuberculosis
recurrence in patients treated with the short-course regimen in Brazil shows as
noncompliance [RR = 6.43 (95% CI: 2.02-20.44)] is proved to be independently
associated with recurrence of tuberculosis (8).
A high treatment default rate (10-20%) was described in Ethiopia which adversely
affected the national cure rate (9, 10). In an effort to reach the national as well as global
target of 85% treatment success and noncompliance rates of TB programs be lower
than 5%((1).   It was wise to identify, describe, and deal with factors determining
treatment compliance. The current study, therefore, aims at determining factors that
predict treatment compliance among TB patients attending TB treatment in public and
private health institutions in Dessie and Kombolcha, Amhara region, North East
Ethiopia.
1.2. Literature review
Compliance to TB treatment
Tuberculosis can be cured only if the anti-TB drugs are taken regularly. People with
tuberculosis require treatment for at least six to eight months. New TB patients
(category-I) are treated with 2 months of (RHZE) and 4 months of (RH) and the
treatment regimen for re-treatment (category II) adults is 2 month of S(RHZE), 1month
of (RHZE) and 5 month of (RH)E. Many find it difficult to complete their course of
treatment and this serves as a major constraint to eradicating the disease. The
uninterrupted availability of drugs and precise organization of treatment delivery will
ensure patients' compliance with treatment (3).
Magnitude of Non Compliance
A prospective cohort study in Awassa, South Ethiopia describes a default rate of 20 %(
9). Another study in Oromia Region, Arsi Zone, Ethiopia shows the overall rate of
defaulting from DOTS was 11.3%, while the rate in sputum smear-positive cases was
11.6%(10). However a higher rate of non compliance (49.2%) was registered in a
community based cross sectional study in Gondar, North West Ethiopia (11). A study in
south India shows a default rate of 20 %(12). A comparable figure (21% and 23%) was
described in Jiangsu province, China and Sri Lanka respectively (13, 14).
3Another study in Jiangsu province in china found that 12% of patients did not take at
least 10% of their prescribed doses of anti-TB treatment (15).
A larger proportion (46%) of patients missed at least 10% of the doses as indicated by a
study in Hebei Province, china (16).
A survey of 45 private for profit practitioners in Philippines asked health workers what
they believed was the percentage of their patients who regularly took treatment up to
the end. Majority of the respondent estimate between 30 and 70% of their TB patients
were non adherent (17).
A systematic review of studies evaluating the impact of public and private healthcare
provision  on TB treatment outcomes describes four of the six studies found that
patients in a private healthcare facility were more likely to interrupt TB treatment than
patients in public healthcare facility OR 2.04 (95% CI 1.07– 3.89(18). Similarly a study
in Delhi, India shows higher rate of treatment interruption in the private health sector
(56.27%) as compared to public DOTS (34.25%)(19). Another study in Thailand also
found higher rate of default in private facilities (92%) compared with (41%) in small and
(40%) in large public facilities (P < 0.01, both comparisons) (20).
However a comparative cross- sectional descriptive study comparing the public and
private facilities providing DOTS services in Nigeria shows a higher defaulter rate
among patients managed by public health facilities (13.0%) compared to only 5.8%
among patients managed by the private facilities (21).  Similarly a study in Bengal
shows a higher rate of default in public hospital 29.30 % compared to only 10.78% in
private hospitals(22).
4FACTORS ASSOCIATED WITH TREATMENT COMPLIANCE
Socio Demographic Factors
Different study in Kenya, Thailand, India show being male was associated with high non
compliance rate (20, 23, 24). While a study in Malaysia identifies no sex difference to
become non compliant (25).
A prospective cohort study conducted in Awassa, South Ethiopia identifies age >25
years (RR = 1.71; p = 0.02) was associated with defaulting from treatment (9). Similarly
a study in Thailand found that older age is associated with defaulting (20).
A study in India shows the percentage of defaulters continued to remain high in the
older age groups both in private and public facilities (22). However a study in Malaysia
identifies no statistical significance for age between compliant and non compliant
patients (25).
A statistically significant (P = 0.043) difference was seen in non-compliant between
single (17.5%), married (27.8%) and other (widowed and divorced) participants (50%) in
Nepal (26). Similar to public facilities being widowed or divorced were found to be
associated with unsuccessful treatment outcomes in private health facilities (20).
Studies in China, Thailand, and South Africa shows increasing educational status were
associated with a lower non compliance rate (15,25, 27).  A study in India shows the
proportion of defaulters decreased uniformly with increasing educational status, the
difference being significant (p<0.05) uniformly both in public and private DOTS centers
(22).
Different studies in Gondar, Ethiopia and Nairobi, Kenya indicate Low income was
significantly associated with non compliance (11, 23). In contrast to that a study in
Malaysia shows high income groups are high risk for non compliance (25). A
comparative study in India shows with increasing family monthly income, the
percentage of defaulters decreased uniformly both in the private and public health
facilities (22). However a study in Arsi Zone, Ethiopia shows no difference between
compliant and non compliant groups regarding monthly family income (10).
5Patient related factors
A case control studies in Arsi Zone, Ethiopia and Kenya, identifies adequate knowledge
to TB were found to be possible protective factors for non compliance (10, 23). Other
different studies in India and Nepal describes similar finding(26, 28). However a study in
Malaysia shows no statistically significant differences between compliant and non
compliant groups for knowledge (25).
A study in Gondar, Ethiopia done to assess the magnitude and factors of non
compliance with medication prescribed for chronic disease describes the reasons why
patients don’t comply with drug regimens as forgetfulness(11). Alcoholism was
described as a significant predictive factor for non compliance in different studies (12,
24, 27, 28).
Social related factors
Family support was found to be possible protective factors for non compliance as
described by a study in Arsi, Ethiopia (10). Studies in China found that observation of
treatment by volunteers and village doctors tended to decrease the chance of non-
compliance (p = 0.06)(13, 15). Similarly a study in India revealed that the patients who
were observed by Government DOTS workers defaulted twice than that of observed by
volunteers (29).
A study in Jiangsu province in China shows social stigma was a significant risk factor for
non compliance (15). Another study in South Africa reveled that feeling ashamed to
have TB (AOR 2.0, 95% CI 1.3–3.0) was associated with non compliance(27).
A retrospective case-control study in Nairobi, Kenya indicates herbal medication use
was significantly associated with default (23). Similar study in South Africa describes
seeing a traditional healer during TB treatment was a significant predictor of non
compliance (27).
Health Care and System Related Factors
A study in Awassa, South Ethiopia identifies distance from home to treatment centre
(HR] = 2.97; p < 0.001) was associated with defaulting from treatment. In addition the
study describes necessity to use public transport to get to a treatment centre (HR =
61.59; p = 0.06) was associated with defaulting from treatment (9). In contrast different
studies in Arsi zone, Ethiopia and Nepal show no statistically significant differences in
distance and mode of travel between compliant and non compliant groups. However,
shorter travelling time was associated with better adherence (10, 26).
Inadequate patient provider interaction [OR-1.72], no support from health staff [OR-
1.93), dissatisfied with services [OR-1.73) were associated with non compliance as
described by a study in India (28). Similar findings were described in a study conducted
in South Africa (27).
As shown by a study conducted in Nepal compliant patients were almost twice as likely
to mention the availability of health education (87%) than non-compliant patients (47%)
(P = 0.001).  About 75% of compliant versus 49% of non-compliant patients confirmed
the presence of daily DOTS at the clinics they attended (P = 0.001). Availability of drugs
and health workers at every visit does not show differences between compliant and non
compliant groups in this study (26).
Studies in Nepal and South Africa describes daily health education and counseling
about TB treatment was independently associated with compliance (26, 27).
A study in south India shows factors for default were inconvenience for DOTS time(12).
Treatment/ disease related Variables
Different studies in Ethiopia and other countries describes medication side effects was
significantly associated with defaulting (10, 11, 13-15). However no statistically
significant differences were found between compliant and non compliant groups to
medication side effects in a study conducted in Malaysia (25).
Studies conducted in Delhi, India and South Africa shows early improvement is the most
common reasons leading to treatment interruption (19, 27). Similar finding was also
described for private health facilities in a study conducted in Philippines (17).
A case-control study in Nairobi, Kenya indicates co-infection with Human immune-
deficient Virus (HIV) were significantly associated with default (23). Another study in
India also describes having other concomitant diseases during treatment [OR-3.22
were independently associated with default (28).
71.3. Justification of the proposed study
Treatment non compliance is required to fall below 5% in order to achieve treatment
success of 85%, one of the targets in WHO STOP TB strategy. To achieve this target
Ethiopia expands the DOTS service to private health institutions starting from 2006 in
line with WHO global recommendation to involve the private sector in the delivery of TB
services. Some studies done in public DOTS centers shows higher non compliance rate
and as no study is done in private DOTS centers nationally as well as in this study area,
the current study, therefore, investigated compliance rate and factors that predict
treatment compliance among registered TB patients in Dessie and Kombolcha, North
East Ethiopia. The finding of this study aimed at developing targeted measures to
scaled-up the Public private mix (PP-M) DOTS strategy to improve patient compliance
and thereby preventing treatment failure, recurrence, drug resistance and Death.
82. OBJECTIVE
2.1. General objective
To assess treatment noncompliance rate and associated factors among registered TB
patients at public and private DOTS clinics in Dessie and Kombolcha, North East
Ethiopia from April 02 to May 04, 2012.
2.2. Specific objectives
 To compare noncompliance rate to drug treatment among registered TB
patients at public and private DOTS clinics in Dessie and Kombolcha.
 To identify factors affecting noncompliance to tuberculosis drug treatment
among TB patients at public and private DOTS clinics in Dessie and
Kombolcha.
93. METHODS
3.1. Study design
A facility based comparative cross sectional study between public and private DOTS
clinics was conducted to assess treatment compliance rate and associated factors
among TB patients.
3.2. Study area and period
The study was conducted at public and private health facilities which provide DOTS
services in Dessie and Kombolcha town which are 380 – 400Km, North-East of Addis
Ababa from April 02 to May 04, 2012.
Administratively Dessie town is divided into 21 Kebeles. According to central statistics
agency population census 2007, the population of the town is estimated to be 151,094.
Based on figures from the Central Statistical Agency in 2007, Kombolcha has an
estimated total population of 85,337. The town has divided with five Kebeles with an
estimated area of 8.66 square kilometers.
There is one referral hospital, one general hospital, three health centers, four upgrading
health centers and six health posts owned by the government in Dessie. Concerning
private health facilities there are three private general hospitals, six higher clinics, five
medium clinics, sixteen junior clinics. From these health facilities the DOTS service is
provided at Dessie referral hospital, Boru-Meda hospital, all of the health centers, all the
three private general hospitals, four of the private higher clinics. Based on South Wollo
Zonal Health Department TB report for 2003, TB case detection rate in Dessie town was
62%.
DOTS service was given at three public health center and two private medium clinics in
Kombolcha town.
Tuberculosis cure rate in Dessie and Kombolcha were 73% and 75.4%, respectively in
2004 E.C.
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3.3. Source population
All registered adult tuberculosis patients at public and private health institutions in South
Wollo Zone, North East Ethiopia.
3.4. Study population
All registered adult TB patients attending their DOTS treatment in public and private
health facilities in Dessie and Kombolcha, South Wollo during the specified study
period.
3.5. Inclusion and exclusion criteria
3.5.1. Inclusion criteria
Tuberculosis patients aged18 years old and above were included in this study. Patients
who had completed two week of treatment days or more were included, as we thought
that they would have more exposure to DOTS and could contribute their feelings and
experiences more extensively during the interview
3.5.2. Exclusion criteria
Patients with mental disorder, severely ill and individuals who are unable to hear were
excluded from the study. In addition those patients who are transferred in were also not
included in this study.
3.6. Sample size
The required sample size for the study was determined using EPI INFO statistical
software version 3.3.2 based on the following assumptions
 p1= 40 %( proportion of non compliant TB patients in public DOTS taken
from a study done in N/Wollo in 2009(30).
 OR=2
 Confidence level or 1- α = 95%
 Power or 1- β = 80%
 Ratio (number of subjects in public DOTS/ number of subjects in private
DOTS) = 1:1 Fitting the above assumptions in to the software the
required minimum sample size is 144 in each group. Adding 5% for non
response rate the final sample size was 152 from each group
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3.7. Sampling procedures:
A total of around 442 TB patients were registered at eight public and seven
private health facilities providing DOTS for tuberculosis during the time of data
collection in the study area, 170 of them were registered in private DOTS clinics.
From private DOTS we took all patients who fulfill our inclusion criteria when they
come to take their drug until our sample reached 152, we thought that the nature
of registration of patients by itself were random.  However proportional allocation
to size was used to select 152 patients using simple random sampling technique
from 272 registered TB patients at public DOTS using the registration list of
patients as a frame.
3.8. Variables of the study:
Dependent variable – compliance to anti TB drug treatment (Yes or No)
Independent variables:
Patient related Variables
1. Socio demographic variables (sex, age. marital status,
educational status, occupation etc )
2. Residence
3. Monthly household income
4. Forgetfulness to take the drug
5. Knowledge on TB
6. Substance abuse
Health care and system related variables
1. Type of Health Facility(public Vs private)
2. Distance (DOTS center to patient home)
3. waiting time
4. Availability of drug on scheduled days
5. Health education
6. DOTS time
7. Availability of health worker  on scheduled days
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Social related variables
1. Stigma
2. Treatment Supporter
3. Use of herbal medicine
Treatment/ disease related Variables
1. Side effect of drugs
2. Early improvement
3. Co morbidity
4. Type of TB
3.9. Operational definitions:
 Compliant - A patient was defined compliant to treatment if the proportion of actual
doses taken of those prescribed was greater than 95%.
 Non -Compliant - Patients who had missed 5% or more of the total prescribed dose
of TB drugs were classified as noncompliant.
 Long waiting time –Staying more than one hour to take/collect the drug at DOTS
center.
 Adequate knowledge about TB – A patient who scores more than three from a six
item questions asked to measure TB knowledge. These questions were derived from
information routinely provided to patients as part of the national TB program. A
correct response was scored with one point. Incorrect or missing responses were
scored with zero points. A total TB knowledge score was created by summing the
scores for all questions. The score ranged from 0 to 6.
 Inaccessible DOTS center – DOTS center located >5Km far from patient home.
 Treatment Interruption- Patients who had missed 1% or more of the total
prescribed dose of TB drugs were classified as treatment interrupter.
 Use of Addictive Substance – A patient who has currently used one or more of
cigarette smoking, alcohol drinking and chat chewing.
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3.10. Data collection procedures (instrument, personnel)
Data collection was carried out by fifteen health professionals (accelerated midwife
trainers at Dessie health Science College and nurses) who were given a one day
intensive training with practical exercises. One health officers and two degree holder
nurses were assigned to supervise the data collection process and the overall
coordination was handled by the principal investigator. The interview was conducted in
the nurse office after the patient is served. The data was supplemented by patient
medical record review and pill count.
3.11. Data quality control measures
To keep the quality of data Standardized structured questionnaire was used. The
English version questionnaire was translated in to Amharic (local language) and then
back to English to maintain its consistence for actual data collection purpose.
The questionnaire was also pre-tested for their accuracy and consistency prior to actual
data collection in Haik (neighboring district) DOTS clinic. Furthermore, the supervisor
and the principal investigator gave feedback and correction on daily basis for the data
collectors before they start daily data collection. Completeness, accuracy, and clarity of
the collected data were checked carefully. Finally the collected data were entered in to
computer using EPI-INFO to maintain its quality.
3.12. Data processing and analysis
Data entry into the computer was carried out using epi Info version 3.5.1 and then
transferred to the Statistical Package for Social Sciences (SPSS) for Windows version
16 for analysis. The main statistical method applied was binary logistic regression and
both bivariate and multivariate analyses were considered. The unadjusted (crude) and
adjusted Odds ratios together with their corresponding 95% confidence intervals were
computed.  A P-value ≤ 0.05 was considered statistically significant in this study. Efforts
were made to assess whether the necessary assumptions for the application of multiple
logistic regression were fulfilled. In this regard, the Hosmer and Lemeshow's goodness-
of-fit test was considered.  A good fit as measured by Hosmer and Lemeshow's test will
yield a large P-value.
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4. ETHICAL CONSIDERATIONS
Ethical clearance was obtained from Institutional Review Board of UoG. In addition
permission to conduct the study was obtained from Amhara Regional Health Bureau,
South Wollo Health Department and Woreda Health Office and from each Health
Facilities prior to data collection. Objective of the study was clearly explained for
participants before conducting the interview and written consent was obtained from
each participant after voluntary participation feature of the study are explained.
Individual records were coded and accessed only by research staff. In addition no
information that identifies individual patients was filled on the data collection format. The
recorded data has kept in a secured place with strict confidentiality. Immediate health
education regarding the danger of treatment interruption was given for participants after
data collection emphasizing more on non compliant patients.
5. DISSEMINATION OF RESULTS
The finding will be disseminated to UoG, ANRSHB, South Wollo health department and
District health office through hard copy, conference presentation and others though
publication on journals.
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6. RESULTS
Socio-demographic characteristics of the respondents
A total of 152 TB patients from public and 152 TB patients from private DOTS clinic,
aged ≥18 years were included by the study, making a response rate of 100%. Of which
158(52 %) were male and 146(48 %) were females. The mean (SD) age for TB patients
from public and private DOTS clinic were 32 (12) and 33(13), respectively. The overall
mean age (SD) was 32(13) years, ranging from 18 to 70 years. About 50% of the
respondents in both groups were young in the age group 18-29 years. Majority of the
patients 262(86.2%) were from the urban areas of Dessie and Kombolcha city. Almost
all respondents were from Amhara ethnic group, 282(92.8%). About two- third of the
patients were self-employed; students constitute 15.1% of the respondents. Over two –
third of the patients were from families with monthly household income of 500-1000
ETB. Islam was the main religion for about 53.3% of the respondents followed by
Orthodox Christian which constituted nearly 42.8% of the overall study subjects.  About
41 (27 %) and 56 (36.8%) of TB patients from public and private DOTS clinic have
attended secondary schooling, respectively. Table 1 shows socio-demographic
characteristics of study population.
Table 1: Socio demographic characteristics of TB patients at public and private DOTS
clinic in Dessie and Kombolcha. South Wollo from April 02 to May 04, 2012.
Variable Health Facility Total (304)
Count (%)Public(n=152)
Count (%)
Private(n=152)
Count (%)
Sex Male 84(55.3) 74(48.7) 158(52)
Female 68(44.7) 78(51.3) 146(48)
Age 18-29 83(54.6) 69(45.4) 152(50)
30-41 38(25) 48(31.6) 86(28.3)
42+ 31(20.4) 35(23) 66(21.7)
Residence Urban 131(86.2) 131(86.2) 262(86.2)
Rural 21(13.8) 21(13.8) 42(13.8)
Religion Islam 91(59.9) 71(46.7) 162(53.3)
Orthodox 56(36.8) 74(48.8) 130(42.8)
Protestant 5(3.3) 7(4.6) 12(3.9)
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Table 1 continued
Ethnicity Amhara 147(96.7) 135(88.8) 282(92.8)
Others 5(3.3) 17(11.2) 22(7.2)
Marital status Married 65(42.8) 70(46.1) 135(44.4)
Single 68(44.7) 63(41.4) 131(43.1)
Divorced/separated 19(12.5) 19(12.5) 38(12.5)
Educational
status
No formal
schooling 34(22.4) 26(17.1) 60(19.7)
Primary 45(29.6) 19(12.5) 64(21.1)
secondary 41(27.0) 56(36.8) 97(31.9)
12+ 32(21.1) 51(33.6) 83(27.3)
Occupational
status
Gov’t Employee 26(17.1) 27(17.8) 53(17.4)
Self employed 49(32.2) 43(28.3) 92(30.3)
Unemployed 42(27.6) 37(24.3) 79(26.0)
Housewife 14(9.2) 20(13.2) 34(11.2)
Student 21(13.8) 25(16.4) 46(15.1)
Monthly
household
income
≤500 61(40.1) 31(20.4) 92(30.3)
501-1000 52(34.2) 53(34.9) 105(34.5)
1001-1499 21(13.8) 35(23.0) 56(18.4)
≥1500 18(11.8) 33(21.7) 51(16.8)
Disease characteristics and compliance level of the respondents
As shown in Table 2, overall, 93.8% of the patients were new cases of TB. There were
fifteen patients from public and four patients from private DOTS clinics on retreatment .
Sixty percent of the overall respondents have a type of pulmonary tuberculosis (PTB
+ve 33% and PTB-ve 27%). The reaming patients (40%) were categorized as having
extra pulmonary tuberculosis. About 40% of the respondents from both groups have a
history of missing at least a dose of their treatment. Among all patients seen in both
public and private DOTS clinics a non- compliance rate of 29.9% was attained. The rate
of treatment non compliance was higher among patients managed by the private DOTS
clinic (32.2%) as compared to patients managed by the public DOTS clinic (27.6%).
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Table 2: Disease characteristics and compliance level of TB patients at public and
private DOTS clinic in Dessie and Kombolcha. South Wollo from April 02 to May 04,
2012.
Public(n=152)
Count (%)
Private(n=152)
Count (%)
Total(n=304)
Count (%)
Case category
New 137(90.1) 148(97.4) 285(93.8)
Re-treatment 15(9.9) 4(2.6) 19(6.2)
Disease category
PTB + 51(33.6) 50(32.9) 101(33.2)
PTB - 46(30.6) 35(23.0) 81(26.6)
EPTB 55(36.2) 67(44.1) 122(40.1)
History of TB treatment Interruption
Yes 59(38.8) 63(41.4) 122(40.1)
No 93(61.2) 89(58.6) 182(59.9)
Compliance level
Compliant 110(72.4) 103(67.8) 213(70.1)
Non compliant 42(27.6) 49(32 .2) 91(29.9)
Associated factors affecting the level of treatment compliance as a whole
As can be noted from table 3 six variables show significant association at a 5% level of
significant during multivariate analysis. In this regard type of health facility, family
income, opening time, distance, and waiting time, closure of TB clinic, stigma, treatment
supporter, side effect, improvement and phase of TB treatment does not show
significant association with compliance level.
However forgetfulness, use of addictive substance, knowledge about TB, availability of
drug, health education, and herbal medication use remained significantly and
independently associated with compliance level at multivariate analysis
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Table-3: Binary logistic regression output showing associated factors affecting the level
of compliance to drug treatment for the study population as a whole, Dessie &
Kombolcha. (Bivariate and multivariate analysis, n=304)
Variables Compliance level COR(95%CI) AOR(95%CI)
Compliant Non
compliant
Health facility Public 110 42 17
Private 103 49 1.25(0.76,2.01)
Monthly household income
≤500 58 34 1
501-1000 71 34 0.82(0.45,1.47)
1001-1499 45 11 0.42(0.19,0.91)
≥1500 39 12 0.52(0.24,1.14)
Forgetfulness No 177 48 1 1
Yes 36 43 4.41(2.55,7.60) 3.45(1.85, 6.46)*
Use of Addictive
substance
No 172 49 1 1
Yes 41 42 3.59(2.11, 6.14) 2.62(1.42, 4.83)*
Knowledge of
TB
Adequate 184 57 1 1
Not
Adequate
29 34 3.78(2.12, 6.74) 2.59(1.31, 5.09)*
Opening Time Convenient 64 37 1
Not
Convenient
149 54 0.63(0.37, 1.04)
Distance to treatment center
≤ 5Km 189 74 1
>5Km 24 17 1.81(0.92, 3.56)
Waiting
Time
≤1 hour 171 63 1
>1hour 42 28 1.81(1.03, 3.16)
Availability of Drug
Always Available 191 64 1 1
Not Always
Available
22 27 3.66(1.95, 6.88) 3.13(1.48, 6.61)*
Closure of TB clinic
No 196 75 1
Yes 17 16 2.46(1.18, 5.12)
19
Table 3 cont…
Variables Compliance level COR(95%CI) AOR(95%CI)
Compliant Non
compliant
Get Health
Education
Yes 154 44 1 1
No 59 47 2.78(1.67, 4.64) 1.98(1.09, 3.61)*
Stigma No 191 75 1
Yes 22 16 1.85(0.92, 3.72)
Has Treatment Supporter
Yes 190 73 1
No 23 18 2.03(1.01, 3.99)
Herbal Medication Use
No 180 53 1 1
Yes 33 38 3.91(2.24, 6.83) 3.07(1.58, 5.95)*
Side effect No 81 24 1
Yes 132 67 1.71(0.99, 2.94)
Improvement Late 99 53 1
Early 114 38 0.62(0.38, 1.02)
Phase of TB treatment
Intensive 109 36 1
Continuation 104 55 1.60(0.97, 2.64)
* remained significant in multivariate analysis at a 0.05 level of significance.
Associated factors affecting the level of treatment compliance separately at
public and private DOTS
Socio demographic, patient, facility and disease related determinants in relation to
treatment compliance were analyzed by bivariate and multivariate analyses using binary
logistic regression model. As can be noted from the findings of the bivariate analyses
(Tables 4 and 5), six of the twenty three variables from public DOTS  and ten of the
twenty three variables from private DOTS clinic shows a significant association with the
outcome variable at a 5% level of significance. In this regard forgetfulness, substance
abuse, knowledge about TB, availability of drug, health education and herbal medication
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use shows significant association with the level of treatment compliance both in patients
at public and private DOTS clinic. In addition marital status, distance to treatment
center, waiting time and closure of TB clinic significantly related with treatment
compliance only in patients attending at private DOTS clinics.
The multivariate logistic regression analysis which controls the undesirable effects of
confounding variables was used by taking all predictor variables into account
simultaneously. Each of these predictor variables showed statistical significance at a 0.2
level of significance (Tables 4 and 5).
The backward stepwise regression which controls the problem of multi co linearity was
employed and only four and seven of the contributing factors remained to be
significantly and independently associated with the level of treatment compliance
among patients at public DOTS clinic and private DOTS clinic, respectively. In this
regard forgetfulness, use of addictive substance and availability of drug remained
significant both in public and private DOTS clinics. Herbal medication use was remained
significantly associated with the level of treatment compliance only among patients
attending public DOTS clinics. Unlike patients at public DOTS clinics monthly income,
knowledge about TB, closure of TB clinic and health education shows significant
association with the outcome variable in multivariate analysis for patients serving at
private DOTS clinic.
Accordingly, patients at public DOTS clinic who forget taking daily dose of their
treatment were 4.75 times more likely to be non compliant as compared to those who
does not forget their daily treatment (AOR = 4.75, 95%CI: 1.96, 11.48). However, the
difference in the level of treatment compliance between patients at private DOTS clinic
who forget and does not forget taking daily dose of their drug shows marginal
significance (AOR=2.39, 95% CI: 0.91, 6.24).
Those patients who currently use addictive substance were more likely to be non
compliant both in patients attending public and private DOTS clinics ((AOR
(95%CI):3.54(1.34, 9.37), AOR (95%CI):2.61(1.11, 6.24), respectively).
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Table-4: Binary logistic regression output showing associated factors affecting the level
of compliance to drug treatment among TB patients attending treatment at public DOTS
center, South Wollo. (Bivariate and Multivariate analysis, n=152)
Variables Compliance level COR(95%CI) AOR(95%CI)
Compliant Noncompliant
Monthly household income
≤500 43 18 1
501-1000 34 18 1.26(0.572,2.796)
1001-1499 19 2 0.25(0.053,1.194)
≥1500 14 4 0.68(0.198,2.359)
Forgetfulness*
No 91 20 1 1
Yes 19 22 5.27(2.41,11.51) 4.752(1.966,11.48)
Substance Abuse*
No 97 27 1 1
Yes 13 15 4.15(1.76,9.76) 3.54(1.336,9.37)
Knowledge of TB
Adequate 95 29 1
Not Adequate 15 13 2.84(1.21,6.65)
Availability of Drug *
Always Available 95 29 1 1
Not Always
Available
15 13 2.839(1.21,6.65) 3.084(1.141,8.33)
Health Education
Yes 79 20 1
No 31 22 2.80(1.34,5.842)
Herbal Medication Use *
No 98 26 1 1
Yes 12 16 5.026(2.12,11.93) 5.646(2.12,15.05)
* remained significant in multivariate analysis at a 0.05 level of significance.
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Table-5: Binary logistic regression output showing associated factors affecting the level
of compliance to drug treatment among TB patients attending treatment at private
DOTS center, South Wollo. (Bivariate and Multivariate analysis, n=152)
Variables Compliance level COR(95%CI) AOR(95%CI)
Compliant Noncompliant
Sex Female 57 21 1
Male 46 28 1.652(0.83,3.28
Marital status
Single 38 25 1
Married 55 15 0.415(0.19,0.89)
Divorced/separated 10 9 1.368(0.48,3.84)
Monthly household income*
≤500 15 16 1 1
500-1000 37 16 0.405(0.16,1.01) 0.196(0.06, 0.64)
1001-1499 26 9 0.325(0.12,0.91) 0.272(0.08, 0.92)
≥1500 25 8 0.300(0.104,0.87) 0.199(0.05, 0.73)
Forgetfulness **
No 86 28 1 1
Yes 17 21 3.794(1.76,8.18) 2.39(0.91,6.24)
Substance abuse *
No 75 22 1 1
Yes 28 27 3.287(1.62,6.69) 2.605(1.108, 6.24)
Knowledge of TB*
Adequate 89 28 1 1
Not Adequate 14 21 4.768(2.15,10.59) 3.460(1.37, 8.75)
Opening Time
Convenient 35 22 1
Not  Convenient 68 27 0.632(0.32,1.27)
Distance
≤ 5Km 90 36 1
>5Km 13 13 2.500(1.06,5.91)
Waiting Time
≤1 hour 84 31 1
>1hour 19 18 2.567(1.19,5.52)
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Table 5 continued
Availability of Drug*
Always Available 96 35 1 1
Not Always Available 7 14 5.486(2.04,14.71) 3.447(1.08,10.95)
Closure of TB clinic*
No 92 36 1 1
Yes 11 13 3.020(1.24,7.36) 3.077(1.01, 9.40)
Get Health Education*
Yes 71 21 1 1
No 32 28 2.958(1.46,5.97) 2.742(1.14, 6.57)
Stigma
No 93 40 1
Yes 10 9 2.092(0.79,5.54)
Has Treatment Supporter
Yes 93 39 1
No 10 10 2.385(0.92,6.18)
Herbal Medication Use
No 82 27 1
Yes 21 22 3.182(1.52,6.66)
Side effect
No 37 11 1
Yes 66 38 1.937(0.88,4.23)
Improvement
Late 61 35 1
Early 42 14 0.581(0.28,1.21)
Phase of TB treatment
Intensive 47 15 1
Continuation 56 34 1.902(0.93,3.91)
* remained significant in multivariate analysis at a 0.05 level of significance.
** Shows marginal significant in multivariate analysis at a 0.05 level of significance
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Patients who mentioned unavailability of drug at each scheduled day where high risk
for treatment non compliance, their risk is more than 3 times both in public and private
DOTS when compared to patients who mentioned availability drug in all their visits.
Our result shows herbal medication use where significantly and independently
associated with noncompliance among patients attending public DOTS clinics
(AOR=5.65, 95%CI=2.12, 15.05). The difference in the variable between public and
private DOTS were significant (P=0.042)
Patients attending private DOTS clinic who have higher monthly income were less likely
to be noncompliant as compared to low income groups (AOR=0.19, 95%CI=0.05, 0.73).
Economically better patients were among patients attending private DOTS, the
difference was significance when compared to patients at public DOTS (p=0.001).
Patients’ Knowledge about TB does not show significance difference at public DOTS
clinics. But those patients at private DOTS with inadequate knowledge were 3.46 times
high risk for noncompliance (AOR=3.601, 95%CI=1.37, 8.75). Closure of TB clinic at
private DOTS was significantly associated with noncompliance, but it does not at public
DOTS. The difference was significant between the two groups (p = 0.04). Private DOTS
who close their clinic at a scheduled day contribute a threefold increase in risk of
noncompliance for their patients.  A significant number of patients attending private
DOTS clinics reported that they do not receive regular counseling and health education
about their treatment regimen and DOTS. These patients were 2.74 times more likely to
be noncompliant as compared to those who had get health education by health workers
(AOR=2.74, 95%CI=1.14, 6.57).
The assessment made whether the required assumptions for the application of multiple
logistic regression was fulfilled showed that the model adequately fits the data (Hosmer
Lemeshow test as P- value= 0.15, 0.56 and 0.18 for Overall, at public and at private
DOTS, respectively)
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Reasons for interrupting treatment
Of the 304 patients, 122 (40.1 %) stopped taking their treatment at some point. Of
these, 91(29.9%) were non compliant (Interrupt at least 5% of their daily dose of
treatment). Most patients who have a history of treatment interruption gave multiple
reasons for interruption of daily dose of their treatment. Traveled to other area
25(20.49%) and forgetfulness 21 (17.21%) were the most frequently mentioned
reasons.  Around 20 (16.4%) of the interrupters said their interruption was due to
unavailability of drug at the clinic during a scheduled time. Other reasons includes: lack
of family support 16 (13%), early improvement 17(14%), severe illness 15(12%), not
being told to regular treatment 14(11.5%), herbal medication use 14(11.5%), working
busy 14 (11.5%), side effect 11(9%) and others 7(5.74%).The percentage was greater
than 100% because of multiple responses. Figure 1: illustrates the reasons mentioned
for treatment interruption.
Figure 1 Reasons for treatment interruption given by the respondents who have a history of
interrupting daily dose of treatment by type of DOTS clinics (n=122)
(Others: distance, unable to afford travel cost, inconvenient opening time)
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7. DISCUSSION
Non-compliance is cited as a major obstacle to the control of tuberculosis at the level of
public health (15, 16).It is also a serious problem in the treatment of individual patients
and in the development of drug resistant strains. Therefore, this study has attempted to
look into the level of compliance in public and private set ups by incorporating as many
risk factors as possible.
Our results show that noncompliance rates were higher among patients attending
private DOTS clinic (32.2%) than among those patients attending public DOTS clinics
(27.6%). This may be due to private DOTS clinic did not strictly adhere to the guidelines
recommended in the DOTS strategy. These finding was higher as compared to studies
done in Arsi Zone and Southern Ethiopia, they investigate a defaulting rate of 11.3%
and 20%, respectively(1, 2). This may be due to the use of higher cut point used to say
noncompliant in those studies (25%). In other ways noncompliance rate of this study
was lower as compared to a study done in India which describes a noncompliance rate
of 56.27% in private DOTS clinics and 34.25% in public DOTS clinics (3). However a
comparative cross- sectional descriptive study comparing the public and private facilities
providing DOTS services in Nigeria shows a higher rate of default in public hospital
29.30 % compared to only 10.78% in private hospitals(22). This shows a better private
health care system in those countries.
This study shows that the main factors influencing noncompliance to Anti TB drugs both
in patients at public and private DOTS clinics were forgetfulness, use of addictive
substance and unavailability of drug at every visit.
Forgetfulness significantly increases the risk of noncompliance. This may be due to the
behavioral nature of the variable and passive participation of treatment supporters. The
same finding was stated in a study done in Gondar, Ethiopa (11).
Our study established that noncompliance was higher in those patients who have
currently use addictive substance, as was shown in different studies (12, 24, 27, 28).
The reason behind that may be addictive patients are not interested in following their
treatment daily and they have a sleep pattern usually in the morning, causes to miss
taking  daily dose.
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A study from Nepal reported that unavailability of drug at every visit in the treatment
center does not show significant difference between compliant and non compliant
groups (26). In the present study unavailability of drug was a significant predictor of
noncompliance among TB patients both in public and private DOTS clinic. Poor
coordination and disorganized management of drug resources throughout the health
care system in our country makes the difference.
The results of this study indicated that statistically significance difference was observed
regarding herbal medication use between public and private DOTS patients. The result
shows that herbal medication use was a significant predictor for noncompliance in
patients at public DOTS center. It does not have a significant association with the level
of treatment compliance among patients at private DOTS clinic. This might be
explained, to some extent, by low educational and economical status of patients at
public DOTS center when compared to patients attending private DOTS clinic. Similar
finding was registered by a study done in Nairobi(23). Similar study in South Africa
describes seeing a traditional healer during TB treatment was a significant predictor of
non compliance (27).
Monthly income, knowledge about TB, closure of DOTS clinic at the scheduled day and
unavailability of health education were the other important determinant factors for
noncompliance among patients at private DOTS clinics. The deference was significance
for the variable monthly income and closure of DOTS clinic between patients served at
public and private DOTS clinics.
Studies, to the contrary of our findings, have shown that monthly income and closure of
DOTS clinics was a significance predictor of noncompliance among public DOTS
patients (26). However a study done in Bengal shows knowledge about TB was
significantly associated with noncompliance both in patients attending public and private
clinics (22).
The study shows high income for patients attending private DOTS clinic have a
protective effect for noncompliance. This was also reported by a study done in India
(22). This may be because patients with high income status were register usually in
private institutions at the start of their TB diagnosis. But a study in Arsi Zone, Ethiopia
shows no difference between compliant and non compliant groups regarding monthly
family income (10).
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The study also found that inadequate knowledge regarding tuberculosis was
significantly increase the risk of non-compliance (O.R. = 3.46, 95% C.I = 1.37, 8.75 and
P = 0.008) among patients attending private health facilities. A large section of the
patients (35/152) were unaware of their disease and treatment regimen. These findings
indicate that patients at private DOTS do not get regular counseling and health
education by the health workers regarding TB and treatment adherence. Different other
studies in Ethiopia, Kenya, India, Nepal (10, 23, 26, 28) identifies adequate knowledge
to TB were found to be possible protective factors for noncompliance. However a study
in Malaysia shows no statistically significant differences between compliant and non
compliant groups for knowledge (25).
The study also confirms that lack of counseling and health education emerged as the
most important determinant of noncompliance in private DOTS. It increased chances of
noncompliance 2.74 times (95% C.I = 1.14, 6.57) compared to those patients who had
been counseled by health worker. This might be due to lack of independent and
responsible health worker for DOTS in private health facilities. Health workers were
busy by other activities to give counseling to the patient. Similar finding was registered
in a study done in Nepal (26).
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8. LIMITATION AND STRENGHT OF THE STUDY
The limitations to this study were, firstly the patients in the compliant group were at
various stages in their treatment, and it is possible that some may have become non-
compliant later. The effect of this on our results would be to reduce the differences
found between the groups, even though it is compensated by patients on the last month
of treatment.
Secondly, data on treatment history and possible explanatory factors in this study were
based on self-report of patients. Recall bias were thus unavoidable. This may have
made results more imprecise. But the study try to cross check self report data with
patient registration book and pill count.
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9. CONCLUSSION
The study has documented a high level of noncompliance rate among both public and
private DOTS clinics. The rate of treatment noncompliance was higher in the private
DOTS, as compared to public DOTS. Forgetfulness, use of addictive substance and
unavailability of drug at each scheduled day were found to be significantly and
independently affects the level of treatment compliance both in patients attending public
and private DOTS clinics. Additionally monthly income, knowledge about TB, closure of
TB clinic and health education was also the most important determinants of
noncompliance in patients at private DOTS clinics. The other crucial determinant of
noncompliance among patients at public DOTS was herbal medication use which does
not show significant relationship with compliance among patients at private DOTS
clinics.
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10. RECOMMENDATION
To concerned NGO’s and South Wollo Zonal Health Department
 There is a need to improve supervision to private health care facilities to ensure
that all DOTS components were implemented there.
 There is need for refresher training of health care providers on the current status
and challenges of tuberculosis control program, to sensitize health care workers
the danger of treatment interruption and to make them accountable in their job.
 It was understood from the present study that there was some evidence
regarding the negative influence of herbal medication use on treatment
compliance. In this regard, there in need to work together with traditional healer,
as they do not order their patients to stop medical treatment while they are on
traditional treatment.
To Health Facilities or DOTS clinics
 It is mandatory to assign a responsible health worker to coordinate DOTS and
balance drug stoke regularly at the clinic, who assures availability of drug always
at each scheduled visit.
 Improved education for patients, their family and the general population may also
improve compliance.
To Tuberculosis Patients
 Tuberculosis patients try to have a functional (active) treatment supporter who
reminds them in taking their daily treatment and it is better if patients use
alarming machines to click them in a schedule time. In this regard all responsible
body may play a crucial role by providing alarming machines to all patients.
To Researchers
 Impact of treatment interruption on treatment outcome need to be studded
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12. ANNEX
12.1. Conceptual frame work
Adopted from Barnhoorn and Adriaanse (1992)
Demographic
factors
 Age
 Sex
 Marital
status
Social
Economic
factors
• Family
income
• Place of
residence
• religion
• Education
• Occupation
Reinforcing
factors
External
• Health
workers'
interest
• family support
Internal
• Symptoms
• Health status
Predisposing
Factors
TB Knowledge
Enabling factors
• Drugs free
of Charge
• Social and
economic
aid
Barriers
• Stigma
• The number of
pills
• co-infection
• substance
abuse
• Waiting time in
clinics
Compliance
Supports
• Open
communication
with care provider
• Presence of
supportive person,
who establishes
routine in taking
pills
Type of Health
Facility
(Public vs private)
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12.2. Survey questionnaire information sheet
You are just invited to participate in a research study to be conducted by MPH student
at University of Gondar. Please read the following statements and ask any thing you are
unclear for it.
Name of Principal Investigator: Yimer Seid
Name of the sponsor: Amhara Regional Health Bureau
Title of the research project: Treatment compliance rate and associated factors
among TB patients in public and private health institutions in Dessie and Kombolcha,
North East Ethiopia.
Purpose of the research project: To assess treatment compliance rate and
associated factors among registered TB patients at private and public TB treatment
centers.
Procedure
Our interview will take about 15 minutes. However you can interrupt the interview at any
time you want without any penalty for you.
Individuals who are below 18 year of old, and who are unable to hear and see and
mentally disabled are not participated in this research.
Participation benefits: participating in this research project will not have any
incentives, but you will get appropriate health service based on our recommendations
for the health facility and if you adhere to the health education given during the survey
you will be cured of your disease.
Participation risks: By participating in this research project, there is totally no risk that
comes to one who gives information for this study. Only you may loss 15 minutes for
interview.
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Confidentiality Your name will not be written on the questionnaire and your answers
will be kept confidential.
Person to contact: This research project will be reviewed and approved by the
institutional review board of college of medicine and health science, University of
Gondar. If in case you want to know more information about the research and its
undertaking, you can contact the committee through the address of the advisor and/or
the principal investigator below.
I. Dr. Getahun Asres(MD, MPH, DTM&H), University of Gondar, Institute
of public health: Advisor
Tel: +251911 066675________ e-mail: Asresgetahun@yahoo.com
II. Yimer Seid , University of Gondar, Institute of public health: Principal
investigator
Tel: +251-911-730505             e-mail: yimer0505@gmail.com
Agree to participate:           Yes             No
Signature _______________                   Date_____________________
38
12. 3. የመረጃ ቅፅ በአማርኛ ቋንቋ
የጥናቱ ርዕስ
በግልና በመንግስት የቲቢ ህክምና ተቋማት የሚገለገሉ የቲቢ ህሙማን የመድሃኒት አወሳሰድ ባህሪ እና ተያያዥ ምክንያቶች፤
ደሴ ፤ሰሜን ምስራቅ ኢትዮጲያ ፡፡
የተመራማሪው ስም፡ ይመር ሰኢድ
የድርጅቱ ስም፡ በጎንደር ዩኒቨርሲቲ ህክምና እና ጤና ሳይንስ ኮሌጅ የህብረተሰብ ጤና አጠባበቅ ተቋም፡፡
የፕሮጀክቱ ስፖንሰር፡ የአማራ ክልላዊ መንግስት ጤና ጥበቃ ቢሮ
የጥናቱ ዓላማ ፡ የጥናቱ ዋና አላማ የቲቢ ህሙማኖች ህክምናቸውን በአግባቡ መውሰድ አለመውሰዳቸውንና ህክምናውን
በአግባቡ እንዳይከታተሉ ያደረጓቸውን ምክንያቶች ለማወቅ የዳሰሳ ጥናት ለማካሄድ ነው፡፡
አተገባበር፡- እርሶ በዕጣ የተመረጡ ሲሆን ጥናቱም የሚከናወነው በእርስዎና በእኔ መካከል በሚደረግ ነጻ ቃለ ምልልስ
ይሆናል፡፡ ቃለ መጠይቁ 15 ደቂቃ የሚወስድ ሲሆን ውይይቱም ሊከናወን የሚችለው የእርሶ መልካም ፈቃድ ሲገኝ ብቻ
ይሆናል፡፡
እድሜአቸው ከ 18 ዓመት በታች የሆኑ ህሙማን፣ በጥና የታመሙ ህሙማን እንዲሁም አካላዊና አእምሮአዊ ችግር
ያለለባቸው ህሙማኖች በጥናቱ አይሳተፉም፡፡
ጥቅም፡- በዚህ ምርምር በመሳተፍዎ በቀጥታ የሚያገኙት ጥቅም ላይኖር ይችላል ነገር ግን በጥናቱ ወቅት በሚሰጠዉ የጤና
ትምህርት ተጠቃሚ ሊሆኑ ይችላሉ ይሄም መዲሃኒትዎን አስተካክለዉ እንድወስዱ በማገዝ ከህመምዎ እንድፈወሱ እገዛ
ያደርጋል፡፡በተጨማሪም በጥናቱ ዉጤት መሰረት በሚሰጠዉ የመፍትሄ ሀሳብ ተጠዋሚ ሊሆኑ ይችላሉ፡፡
ሊገጥም የሚችል ችግር ወይም አለመመቸት
መጠነኛ ከሆነ የሰዓት ብክነት (15 ደቂቃ) በስተቀር በጥናቱ በመሳተፍዎ ምክንያት ምንም ዓይነት ችግር እንደማይደርስቦ
ላረጋግጥሎት ዕወዳለሁ፡፡
ሚስጥራዊነት
በዚህ ምርምር ፕሮጀክት የተሰበሰበ መረጃ ሚስጥራዊ ይሆናል፡፡ በዚህ ቅፅ የእርሰዎ ስም አይፃፍበትም በተጨማሪም
እርስዎ ከሚሰጡን መረጃ ጋር አይያያዝም፡፡
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ያለመሳተፍ ወይም የማቋረጥ መብት
በዚህ ጥናት ያለመሳተፍ ፍፁም የሆነ መብት አለዎት ፡፡ መመለስ እማትፈልገው/እማትፈልጊው ጥያቄ ካለ
አትገደድም/አትገደጅም በተጨማሪ በማንኛው ሰዓት የማቋረጥ ፍላጎትህ/ሽ የተጠበቀ ነው፡፡
ለተጨማሪ ዝርዝር መረጃ ከዚህ በታች ባለው አድራሻ ዋና ተመራማሪውን ወይም የጥናቱን አማካሪ ማግኘት ይችላሉ፡፡
ይመር ሰኢድ፡- ሞባይል +251911730505 - ዋና ተመራማሪ
ዶ/ር ጌታሁን አስረስ፡- ሞባይል +251911 066675 - አማካሪ
ስምምነት
በዚህ መሰረት በጥናቱ ለመሳተፍ ፈቃደኛ ነህ/ነሽ? ምርጫህን/ሽን ከታች በተዘጋጀው ሳጥን ውስጥ የራይት(√) ምልክት
በማድርግ ግለፅ፡፡
አዎ ፈቃደኛ ነኝ
ፈቃደኛ አይደለሁም
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12.4. Consent Statement in English
University of Gondar
College of Medicine and Health Sciences
Institute of Public Health
How are you, my name is ----------------------. I am here on behalf of Yimer Seid, Master
of Public Health student in Gondar University, College of Medicine and Health Sciences,
Institute of Public Health.
I would like to ask you a few questions about your socio-demographic status, your
treatment compliance status and some related factors as health facility, social and
disease related factors for a study entitled as treatment compliance and associated
factors among TB patients in public and private health institutions in Dessie, North East
Ethiopia.
This will help us to improve The DOTS program both in private and public center. Your
name will not be written in this form and will never be used in connection with any
information you tell us.
All information given by you will be kept strictly confidential. Your participation is
voluntary and you are not obligate to answer any question which you do not wish to
answer. If you fill discomfort with this, please fill free to drop it any time you want. This
will take about 15 minutes. Could I have your sign to continue?
Yes____________           No_______________
Data collector’s Name--------------------------------signature------------------ date-----------
THANK YOU!!
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12.5. የስምምነት ማረጋገጫ ቅፅ በአማርኛ ቋንቋ
የጎነደር ዩኒቨርስቲ
የህክምና እና ጤና ሳይንስ ኮሌጅ
የህብተሰብ ጤና ተቋም
ጤና ይስጥልኝ ስሜ ………………… ይባላል፡፡ የመጣሁት ከጎንደር ዩኒቨርስቲ የህብተሰብ ጤና ትምህርት
ቤት ነው፡፡ በጎንደር ዩኒቨርሲቲ የህብረተሰብ ጤና ትምህርት የጥናት ቡድን አባል ነኝ፡፡
በመጀመሪያ ልገለጽሎት የምፈልገው ጥናቱን በተመለከተ ከእርስዎ ጋር አጠር ያለ ቃለ መጠይቅ ለማድረግ
መፈለጌን ሲሆን ከዚህ ቀጥሎ የማቀርብሎትን መግለጫ በጥሞና እንዲያዳመጡኝ በአክብሮት እጠይቆታለሁ፡፡
የጥናቱ ዋና አላማ የሳንባ ነቀርሳና ከሳንባ ውጭ ያሉ የነቀርሳ ህሙማኖች ህክምናቸውን በአግባቡ መውሰድ
አለመውሰዳቸውንና ህክምናውን በአግባቡ እንዳይከታተሉ ያደረጓቸውን ምክንያቶች ለማወቅ የዳሰሳ ጥናት
ለማካሄድ ነው፡፡ ለዚህም እርሶ የተመረጡ ሲሆን ጥናቱም የሚከናወነው በእርሶና በእኔ መካከል በሚደረግ ነጻ ቃለ
ምልልስ ይሆናል፡፡ ውይይቱም ሊከናወን የሚችለው የእርሶ መልካም ፈቃድ ሲገኝ ብቻ ይሆናል፡፡ በሌላ በኩል
ሊመልሷቸው የማይፈልጓቸው ጥያቄዎች ካሉ ለመመለስ የማይገደዱ ሲሆን በተጨማሪም በማንኛውም ሰዓት
ተሳትፎዎን ማቋረጥ ከፈለጉ ለማቋረጥ ሙሉ ዓመት ያሎት መሆኑን ላረጋግጥሎት እወዳለሁ፡፡ ይሁን እንጂ ጥናቱን
በገዛ ፈቃዶ ቢቀጥሉ ከጥናቱ ውጤት እረሶ ቤተሰቦና ብሎም ሀገሮ ተጠቃሚ ሊሆኑ ይችላሉ፡፡ ከዚህ ውጭ
በጥናቱ በመሳተፎ ምክኒያት ምንም ዓይነት ችግር እንደማይደርስቦ ላረጋግጥሎት ዕወዳለሁ፡፡
ይህን ካልን በጥናቱ ለመሳተፍ ፍቃደኛ ነዎት? በፊርማዎ ያረጋግጡልኝ
አዎ______________________ አይደለሁም ______________
አመሰግናለሁ
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12.6. Interviewer administered Questionnaires in English
Part I Socio-demographic and economic characteristics of respondents
S.NO QUESTION AND FILTERS CODING CATEGORIES SKIP
1 Address of the patient Kebele____________
Registration NO _______
2 Sex of the respondent 1. Female
2. Male
3 Age of the respondent _________________
4 Place of Residence 1. Urban
2. Rural
5 Ethnicity 1. Amhara
2. Oromo
3. Tigre
4. other(specify)__________
6 Religion 1. orthodox
2. Muslim
3. protestant
4. Other(specify)______
7 Marital status 1. Single
2. Married
3. Divorced/widowed
8 Educational status 1. No formal schooling
2. Primary
3. Secondary
4. 12+
9. Occupational status 1. Government employee
2. Self employed
3. Unemployed
4. Other (specify)__________
10 Household monthly income in Birr ___________________
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Part II Questions to assess patient related factors affecting compliance
S.NO QUESTION AND FILTERS CODING CATEGORIES SKIP
11 Did you ever forget to take
your TB medication
1. No
2. Yes
12 Have you take addictive substance,
like Cigarette, alcohol and khat
currently?
1. No
2. Yes
13
Knowledge about
Tuberculosis(based on the sum of
scores from the following six
questions)
1. Adequate(if score >3)
2. Not-adequate(if score < =3)
13.1 A person with TB can be cured 0. No
1. Yes
13.2 Someone who has TB always has
HIV/AIDS
0. Yes
1. No
13.3 You can die from TB if you do not
take your drugs regularly
0. No
1. Yes
13.4 TB treatment usually takes at least
6 month.
0. No
1. Yes
13.5 TB medicine is taken daily 0. No
1. Yes
13.6 You should stop taking TB drugs as
soon as you feel better
0. Yes
1. No
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Part III Questions to assess health-care and system related factors affecting
compliance
S.NO QUESTIONS AND FILTERS CODING CATEGORIES SKIP
14 Does TB clinic opening time
convenient for you?
1.Yes
2. No
15 What would be the most convenient
TB clinic opening time for you? __________
16 How far is your home to your
treatment center(in KM) ________________Km
17 How much time do you usually wait
at the TB clinic before being
attended?
1. Less than 1 hour
2. 0ne to two hour
3. Greater than 2 hour
18 What is your means of
transportation to your treatment
center?
1. On foot
2. Public transport
3. Others(specify)______
19 When you come to pick your drugs
at the TB clinic, what would you say
about the availability of drugs here?
1. Always available
2. Not always available
20 Did you ever face a problem of
closing of DOTS center or Absence
of health workers in this unit?
1. No
2. Yes
21 Have you ever get health education
about your treatment, side effect of
drugs, danger of non compliance
etc. by HCWs?
1. No
2. Yes
22 How would you rate the attitude of
HWs who attends you at the health
facility?
1. Very friendly
2. Friendly
3. Unfriendly
45
Part IV Questions to assess social related factors.
S.NO QUESTIONS AND FILTERS CODING CATEGORIES SKIP
23 Did you inform your
friends/relatives that you are on
TB treatment?
1. No
2. Yes
24 If NO fro Q-22, Is that due to fear
of being Isolated (stigma)?
1. No
2. Yes
25 Who provide you support and
encouragement to continue and
complete your anti-TB treatment?
1. health facility worker
2. Health extension worker
3. A family member
4. Community leader
5. Religious leader
6. Has no treatment supporter
26 Have you ever tried traditional
medicine for your TB illness?
1. No
2. Yes
Part V treatment and disease related factors
27 Did you experience any side
effect when you were taking TB
treatment?
1. No
2. Yes
28 If yes to Q-26, which side effect
did you experience?
1. Skin rash
2. Headache and dizziness
3. Yellow eyes
4. Vomiting and confusion
5. Orange/red urine
6. Other(specify)__________
29 From the day you started taking
your TB medicines how long did it
take you before you fell well?
____________week
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Part V cont….
S.NO QUESTIONS AND FILTERS CODING CATEGORIES SKIP
30 Disease category? (circle appropriately
according to treatment card or TB
register)
1. New
2. Re-treatment
31 Disease classification?( circle
appropriately  according to treatment card
or TB register)
1. PTB-SM+
2. PTB-SM-
3. EPT
32 HIV/AIDS status(as indicated on
treatment  card or TB register)
1. Positive
2. Negative
3. Not Indicated/known
33 Was the patient taking other medicines
Besides TB treatment?
1. No
2. Yes
34 If Yes for Q-32, which medicine was the
patient taking?
1. HAART
2. Anti-Hypertensive
3. Psychiatric Drugs
4. Others(specify)
Part VI. Compliance status of the respondents, to be filled by cross-checking with
patient’s registration Book and Pill counting.
S.NO QUESTION AND FILTERS CODING CATEGORIES SKIP
35 When did you start taking Anti-TB drug Date/month/year E.C
____/_____/________
36 For how long did you take TB drug __________day
37 Did you miss any of your daily TB
medication
1. No
2. Yes
38 If yes for Q-32 and Q-36, Is those missed
doses are really TB drugs?
1. Yes
2. No
39 If yes for Q-36, how many days did you
miss to take your medication? -----------------day
40 Why did you miss taking your
medications?
1.________________________
2. _______________________
3.________________________
4_________________________
5.________________________
6.
Thank you
(Name Of data Collector _______________________Date ___________Sign___
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12.7. የአማርኛ ቋንቋ መጠይቅ
ክፍል አንድ፡- የህሙማኑን የግልና የማህበራዊ ሁኔታ በተመለከተ የቀረበ መጠይቅ
ተ.ቁ የጥያቄዎች ዝርዝር የመልስ ኮድ ቁጥር ወደ እለፍ
1 የህሙማኑ አድራሻ ቀበሌ__________ የሰፈር ስም__________
የህክምና መዝገብ ቁጥር_______________
2 የህሙማኑ ፆታ 1. ሴት 2. ወንድ
3 የህሙማኑ ዕድሜ ___________ዓመት
4 የመኖሪያ ቦታ 1. ከተማ 2. ገጠር
5 ብሄር 1. አማራ 3. ኦሮሞ
2- ትግሬ 4. ሌላ(ይገለፅ)__________
6 ሐይማኖትዎ 1. ኦርቶዶክስ 2. እስልምና
3-ፕሮቴስታንት 4. ሌላ(ይገለፅ) ________
7 የህሙማኑ የጋብቻ
ሁኔታ
1. ያላገባ/ች 2. ያገባ/ች
3- የተፋታ/በሞት የተለየ/ች
8 የህሙማኑ የትምህርት
ደረጃ
1. መደበኛ ትምህርት ያልተማረ/ች
2. አንደኛ ደረጃ
3. ሁለተኛ ደረጃ 4. ከ 12ኛ ክፍል በላይ
9. የህሙማኑ የስራ
ሁኔታ
1- የመንግስት ስራ 2. የግል ተቀጣሪ
3- ስራ አጥ 4. ሌላ(ይገለፅ) ______
10 የቤተሰቡ የወር ገቢ
በ ብር/በአይነት ___________________
ክፍል ሁለት፡- ከህሙማኑ የግል ችግሮች ጋር የተያያዙ የበሽተኛዉን የመድሃኒት
አወሳሰድ ባህሪ የሚወስኑ ሁኔታዎችን በተመለከተ የቀረበ መጠይቅ
ተ.ቁ የጥያቄዎች ዝርዝር የመልስ ኮድ ቁጥር ወደ እለፍ
11 መድሃኒትዎን መዉሰድ ረስተዉ ያዉቃሉ? 1- የለም 2. አዎ
12 ሱስ የሚያሲዙ ነገሮችን እንደ ጫት፣ ሲጋራ
እና የአልኮል መጠጥ አሁን ይጠቀማሉ?
1. የለም
2. አዎ
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13 ህሙማኑ ለቲቢ ያለዉ እዉቀት ምን ያክል
ነዉ(ከታች በተዘረዘሩት ስድስት ነጥቦች
ዉጤት መሰረት የሚሞላ)
1. በቂ ነዉ(ስኮር >3)
2. በቂ አይደለም (ስኮር
< =3)
13.1 ቲቢ ሙሉ በሙሉ የሚድን በሽታ ነዉ? 0. አይደለም 1. ነው
13.2 ቲቢ ያለበት ህሙማን ኤድስ አለበት ብሎ
መደምደም ይቻላል?
0. ይቻላል
1. አይቻልም
13.3 መድሃኒቱን በትክክል የማይወስድ የቲቢ
በሽተኛ ሊሞት ይችላል?
0. የለም
1. አዎ
13.4 የቲቢ ህክምና በትንሹ 8 ወር ይፈጃል? 0. አይደለም 1. አዎ
13.5 የቲቢ ህክምና ቀን በቀን የሚወሰድ ነዉ ? 0. አይደለም 1. ነው
13.6 ህመሙ ቀድሞ ከተሸለህ/ሽ የቲቢን መድሃኒት
መዉሰድ ማቆም ትችላለህ/ሽ?
0. አዎ
1. አይደለም
ክፍል ሶስት፡- የህሙማኑን የመድሃኒት አወሳሰድ ባህሪ የሚወስኑ ከጤና ተቋሙ ጋር
ተያያዥነት ያላቸዉ ሁኔታዎችን በተመለከተ የቀረበ መጠይቅ
ተ.ቁ የጥያቄዎች ዝርዝር የመልስ ኮድ ቁጥር ወደ እለፍ
14 የቲቢ ክሊኒኩ የሚከፈትበት ሰዓት ላንተ
አመች ነዉ?
1. አዎ
2. አይደለም
15 የቲቢ መድሃኒትህን ለመዉሰድ አመች
የሚሆንልህ ጊዜ ስንት ሰዓት ላይ ነዉ?
በኢትዮጲያ ሰዓት
----------------
16 መኖሪያ ቤትህ የቲቢ መድሃኒት
ከምትከታተልበት የጤና ተቋም ምን ያክል
ይርቃል(በኪሎ ሜትር)?
________________ኪ.ሜ
17 መድሃኒትህን ለመዉሰድ/ለመቀበል
ባማካኝ ምን ያክል ጊዜ በጤና ተቋሙ
ትጠብቃለህ/ሽ?
1. ከአንድ ሰዓት በታች
2. ከአንድ እስከ ሁለት ሰዓት
3. ከሁለት ሰዓት በላይ
18 መድሃኒትህን ለመዉሰድ ስትመጣ
ባብዛሀኛዉ የምትጠቀምበት መጓጓዣ
ምንድን ነዉ?
1. በእግር
2. በህዝብ ትራንስፖርት
3. ሌላ(ይገለፅ)-------------
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19 መድሃኒትህን ለመዉሰድ ስትመጣ በዚህ
ተቋም ስላለዉ የመድሃኒት አቅርቦት ምን
ትላለህ?
1. ሁልጊዜ አለ
2. አልፎ አልፎ የለም
እባላለሁ
20 መድሃኒት የምትወስድበት ክፍል መዘጋት
ወይም የጤና ባለሙያዉ አለመኖር ችግር
አጋጥሞህ ያዉቃል?
1. የለም
2. አዎ
21 መድሃኒቱን በትክክል አለመዉሰድ
ስለሚያስከትለዉ ችግር የጤና ትምህርት
በጤና ባለሙያዉ አግኝተዉ ያዉቃሉ?
1. አዎ
2. የለም
22 የጤና ባለሙያዎች ለቲቢ ህሙማን ያላቸዉን
አመለካከት እንደት ትመዝነዋለህ?
1. ጥሩ ነዉ
2. መጥፎ ነዉ
ክፍል አራት፡- የህሙማኑን የመድሃኒት አወሳሰድ ባህሪ የሚወስኑ ከማህበራዊ ጉዳዮች ጋር
ተያያዥነት ያላቸዉ ሁኔታዎችን በተመለከተ የቀረበ መጠይቅ
ተ.ቁ የጥያቄዎች ዝርዝር የመልስ ኮድ ቁጥር ወደ እለፍ
23 የቲቢ መድሃኒት እየወሰድክ/ሽ መሆኑን
ለቤተሰብህ/ሽ ወይም ለጓደኞችህ
ነግረሀቸዋል?
1. የለም
2. አዎ
መልስዎ
አዎ ከሆነ
ወደ 25
24 ለጥያቄ ቁጥር 22 የለም ከሆነ መልስዎ፣
ምክንያቱ መገለልና መድሎ ይሆን)?
1. የለም
2. አዎ
25 መድሃኒትህን በትክክል እንድትወስድ
የሚያግዝህ የህክምና ረዳትህ/ሽ ማን
ነዉ
1. የጤና ባለሙያ
2. የጤና ኤክስቴንሽን ሰራተኛ
3. የቤተሰብ አባል
4. የማህበረሰቡ ተወካይ
5. የሀይማኖት መሪ
6. የለኝም
26 ለቲቢ ህመመዎ የባህላዊ ህክምና
ተጠቅመዉ ያዉቃሉ
1. የለም
2. አዎ
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ክፍል አምስት፡- የበሽተኛዉን የመድሃኒት አወሳሰድ ባህሪ የሚወስኑ ከበሽታዉ ባህሪ እና ከ
ህክምናዉ ጋር ተያያዥነት ያላቸዉ ሁኔታዎችን በተመለከተ የቀረበ መጠይቅ
27 የቲቢ መድሃኒት ስትወስድ ከ መድሃኒቱ
ጋር ተያያዥነት ያለዉ የጎንዮሽ ችግር
አጋጥሞህ/ሽ ያዉቃል?
1. የለም
2. አዎ
መልስዎ
የለም ከሆነ
ወደ 29
28 ለጥያቄ ቁጥር 26 አዎ ከሆነ መልስዎ፤
የትኛዉ የጎንዮሽ ችግር ነዉ
ያጋጠመዎት?
1. የቆዳ ሽፍታ
2. እራስ ምታትና ማዞር
3. የአይን ቢጫ መሆን
4. ማስታዎክና ብዥታ
5. የሽንት መቅላት
6. ሌላ(ይገለፅ)__________
29 የቲቢ መድሃኒት መዉሰድ ከጀመሩ በኋላ
ከህመሙ ለማገገም ምን ያክል ጊዜ
ፈጅቶበዎታል?
____________ሳምንት
30 ህሙማኑ ከ የትኛዉ የቲቢ ታካሚዎች
ምድብ ይመደባል? (የህሙማኑን የህክምና
ካርድ ወይም መዝገብ በማየት ይመለስ)
1. ከአዲስ የቲቢ ህሙማን
2. የድጋሚ የቲቢ ህሙማን
31 ህሙማኑ የትኛዉ የቲቢ አይነት ነዉ
ያለበት? (የህሙማኑን የህክምና ካርድ
ወይም መዝገብ በማየት ይመለስ)
1. በአክታ የተረጋገጠ የሳንባ ቲቢ
2. በአክታ ያልተረጋገጠ የሳንባ
ቲቢ
3. ከሳንባ ዉጭ የሆኑ ቲቢ
32 የቲቢ ህሙማኑ የ ኤችአቪ ኤድስ ሁኔታ
ይታወቃል? (የህሙማኑን የህክምና ካርድ
ወይም መዝገብ በማየት ይመለስ)
1. ፖዘቲቭ
2. ነጋቲቭ
3. አይታወቅም/አልተገለፀም
33 ከቲቢ መድሃኒት ዉጭ ሌላ መድሃኒት
ይወስዳሉ?
1. የለም
2. አዎ
34 ለጥያቄ ቁጥር 32 አዎ ከሆነ መልስዎ
የትኛዉን መድሃኒት ነዉ የሚወስዱት
(የህሙማኑን የህክምና ካርድ ወይም
መዝገብ በማየት ይረጋገጥ)
1. የኤችአቪ መድሃኒት
2. የደም ግፊት መድሃኒት
3. የአእምሮ በሽታ መድሃኒት
4. ሌላ(ይገለፅ)----------------
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ክፍል ስድስት፡ የቲቢ ህሙማኑ ከሚሰጠዉ መድሃኒት ጋር ያለዉ የመተማመን ሁኔታ
በተመለከተ የቀረበ መጠይቅ
ተ.ቁ የጥያቄዎች ዝርዝር የመልስ ኮድ ቁጥር ወደ
እለፍ
35 የቲቢ በመድሃኒት መዉሰድ የጀመርከው/ሽዉ መቼ
ነዉ (የህሙማኑን የህክምና ካርድ ወይም መዝገብ
በማየት ይረጋገጥ)
ቀን/ ወር/ ዓመት
በኢትዮጲያ የቀን
አቆጣጠር
____/_____/_____/
36 የቲቢ መድሃኒት መዉሰድ ከጀመሩ ምን ያክል ጊዜ
ሆነዎት(ከጀመሩበት እስከ ዛሬ ቀን ድረስ ያለዉ ጊዜ) __________ቀን
37 መድሃኒትዎን መዉሰድ/መዋጥ ያቋረጡበት ጊዜ ይኖር
ይሆን
1. አዎ
2. የለም
38 ያቋረጡት መድሃኒት የቲቢ ስለመሆኑ እርግጠኛ ነዎት 1. አዎ
2. የለም
39 ለጥያቄ ቁጥር 36 አዎ ከሆነ መልስዎ ምን ያክል ጊዜ
አቋርጠዋል/ረስተዋል((የህሙማኑን የክትትል መዝገብ
በማየት ወይም ትርፍ መድሃኒት በመቁጠር ይረጋገጥ)
----------------ቀን
40 መድሃኒትዎን ለማቋረጥ ምክንያት የሆነዎት ነገር
ምንድን ነበር?
ጨርሰናል፡ በጣም አመሰግናለሁ፡፡
የጤና ተቋሙ አይነት፡ የግል የመንግስት
የመረጃ ሰብሳቢዉ ስም------------------------------------- ቀን --------------------------
ፊርማ------------
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